Inventor · disambiguated record
Michael Edge
Also filed as: EDGE MICHAEL · EDGE MICHAEL D · EDGE MICHAEL DEREK
8 granted patents·4 pending applications·49 citations·filing 1972–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0177US6903203B2Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic useASTRAZENECA UK LTD·Filed 2001·Granted Jun 7, 2005·12 cites·12 claims
- 0270US5247081AProtected biotin derivativesICI PLC·Filed 1988·Granted Sep 21, 1993·11 cites·8 claims
- 0367US4304788AHydroxyalkanoic acid derivativesICI LTD·Filed 1980·Granted Dec 8, 1981·10 cites·7 claims
- 0462US4310544AHydroxyacetic acid derivatives with anti-arthritic propertiesICI LTD·Filed 1980·Granted Jan 12, 1982·7 cites·11 claims
- 0554US2004117863A1Transgenically produced fusion proteinsFiled 2003·Application pending·0 cites
- 0652US12409156B2Stable aqueous hydroxycarbamide solutionNOVA BIO PHARMA PRODUCT DEV LTD·Filed 2019·Granted Sep 9, 2025·0 cites·20 claims
- 0752US2025302779A1Stable aqueous hydroxycarbamide solutionNOVA BIO PHARMA PRODUCT DEV LTD·Filed 2025·Application pending·0 cites
- 0851US2006068480A1Polypeptides and polypeptide analoguesOLIVER WIEDOW·Filed 2005·Application pending·0 cites
- 0949US3935184ASynthetic polyoxin type nucleosidesSYNTEX INC·Filed 1972·Granted Jan 27, 1976·5 cites·16 claims
- 1048US2006026695A1Transgenically produced fusion proteinsEDGE MICHAEL D·Filed 2005·Application pending·0 cites
- 1147US6893843B2Nucleic acidsFiled 2001·Granted May 17, 2005·0 cites·7 claims
- 1240US6277599B1Anti-CEA antibody designated 806.077, hybridoma and method of manufactureZENECA LTD·Filed 1997·Granted Aug 21, 2001·4 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →